Last update 21 Jun 2024

NGGT-001

Overview

Basic Info

Drug Type
AAV based gene therapy
Synonyms
NGGT 001, NGGT001
Target
CYP4V2
Mechanism
CYP4V2 modulators(cytochrome P450 family 4 subfamily V member 2 modulators)
Therapeutic Areas
Congenital DisordersEye DiseasesOther Diseases
Active Indication
Retinal DegenerationRetinitis Pigmentosa
Inactive Indication-
Originator Organization
NGGT (Suzhou) Biotechnology Co., Ltd.NGGT (Suzhou) Biotechnology Co., Ltd.
Active Organization
NGGT (Suzhou) Biotechnology Co., Ltd.NGGT (Suzhou) Biotechnology Co., Ltd.
Inactive Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
RegulationOrphan Drug (US)

Related

3
Clinical Trials associated with NGGT-001
CTR20240103 / RecruitingPhase 1/2
NGGT001视网膜下腔注射治疗结晶样视网膜变性的I/II期临床研究
[Translation] Phase I/II clinical study of NGGT001 subretinal injection for the treatment of crystalline retinal degeneration
NCT06302608 / Active, not recruitingEarly Phase 1IIT
Clinical Trial on the Safety and Effectiveness of Subretinal Injection of NGGT001 for Treating Crystalline Retinal Degeneration
ChiCTR2300067839 / SuspendedPhase 1IIT
A clinical study on the safety and efficacy of subretinal injection of NGGT001 for Bietti crystalline dystrophy
100 Clinical Results associated with NGGT-001
Login to view more data
100 Translational Medicine associated with NGGT-001
Login to view more data
100 Patents (Medical) associated with NGGT-001
Login to view more data
100 Deals associated with NGGT-001
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Retinal DegenerationPhase 2
CN
NGGT (Suzhou) Biotechnology Co., Ltd.
21 Mar 2024
Retinitis PigmentosaIND Approval
US
NGGT (Suzhou) Biotechnology Co., Ltd.
01 Apr 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free